Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives
  • Home
  • /
  • Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives
  1. Home /
  2. Archives /
  3. Vol. 41 (2025) /
  4. Medical Sciences

Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives

Authors

  • Adriana Skuba University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0002-1474-8039
  • Katarzyna Załuska University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0000-3189-5925
  • Agnieszka Świdniak University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0005-4336-188X
  • Marta Biskup University of Rzeszów Al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0001-8760-2930
  • Aleksandra Bartoszek University of Rzeszów Al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0008-2071-3821
  • Karolina Kopeć University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0001-1257-7865
  • Agnieszka Marut University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0005-4884-7854
  • Jagoda Misiuk University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0002-6227-7155
  • Julia Adamiuk University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0003-5857-7646
  • Sylwia Nykiel University of Rzeszów al. Tadeusza Rejtana 16C, 35-310 Rzeszów, Poland https://orcid.org/0009-0007-6967-8927

DOI:

https://doi.org/10.12775/QS.2025.41.58829

Keywords

Alzheimer's disease, amyloid, tau, inflammation, dementia, acetylcho, acetylcholinesterase inhibitors, gene therapy

Abstract

Introduction and Purpose:

Alzheimer’s disease is the most common cause of dementia, affecting millions of people worldwide and posing a significant challenge to modern medicine. This review explores the available treatment options, their limitations, and the future directions of research that may bring breakthroughs in combating this devastating condition.

Materials and Methods:

This article is a comprehensive review based on a detailed analysis of peer-reviewed studies obtained from major scientific databases, such as PubMed. The selected articles focus on modern methods of treating Alzheimer’s disease, chosen for their relevance and importance to the subject.

Results:

This review highlights the complex pathogenesis of Alzheimer’s disease (AD), driven by amyloid-β accumulation, tau protein abnormalities, cholinergic deficits, and neuroinflammation. Current treatments, such as cholinesterase inhibitors and NMDA receptor antagonists, provide only temporary symptom relief, while emerging therapies, including immunotherapy and gene therapy, offer promising new directions. Advances in disease-modifying approaches targeting Aβ, tau, and genetic factors have shown potential, though challenges remain in achieving long-term efficacy and accessibility.

Conclusion:

Despite significant progress in understanding AD and developing new treatment strategies, an effective cure remains elusive. Immunotherapies and gene therapy represent promising avenues for disease modification, but further research is needed to optimize their effectiveness and accessibility. A multidisciplinary approach combining pharmacological, genetic, and lifestyle interventions is essential to improving patient outcomes and combating this devastating disease.

References

1. Kumar A, Sidhu J, Lui F, Tsao JW. Alzheimer Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; February 12, 2024.

2. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327-406. doi:10.1002/alz.12328

3. Rostagno AA. Pathogenesis of Alzheimer's Disease. Int J Mol Sci. 2022;24(1):107. Published 2022 Dec 21. doi:10.3390/ijms24010107

4. Shokri-Kojori E, Wang GJ, Wiers CE, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A. 2018;115(17):4483-4488. doi:10.1073/pnas.1721694115

5. Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD. Traumatic Brain Injury and Risk of Neurodegenerative Disorder. Biol Psychiatry. 2022;91(5):498-507. doi:10.1016/j.biopsych.2021.05.025

6. Yarns BC, Holiday KA, Carlson DM, Cosgrove CK, Melrose RJ. Pathophysiology of Alzheimer's Disease. Psychiatr Clin North Am. 2022;45(4):663-676. doi:10.1016/j.psc.2022.07.003

7. Hampel H, Hardy J, Blennow K, et al. The Amyloid-β Pathway in Alzheimer's Disease. Mol Psychiatry. 2021;26(10):5481-5503. doi:10.1038/s41380-021-01249-0

8. Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023;20(1):165. Published 2023 Jul 14. doi:10.1186/s12974-023-02853-3

9. Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2018;141(7):1917-1933. doi:10.1093/brain/awy132

10. Li Y, Wang R, Li Q, Wang YJ, Guo J. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives. J Alzheimers Dis. 2021;83(3):963-976. doi:10.3233/JAD-210381

11. Bent-Ennakhil N, Coste F, Xie L, et al. A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients. Neurol Ther. 2017;6(1):131-144. doi:10.1007/s40120-017-0067-7

12. Winblad B, Graf A, Riviere ME, Andreasen N, Ryan JM. Active immunotherapy options for Alzheimer's disease. Alzheimers Res Ther. 2014;6(1):7. Published 2014 Jan 30. doi:10.1186/alzrt237

13. Song C, Shi J, Zhang P, et al. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond. Transl Neurodegener. 2022;11(1):18. Published 2022 Mar 18. doi:10.1186/s40035-022-00292-3

14. Guo X, Yan L, Zhang D, Zhao Y. Passive immunotherapy for Alzheimer's disease. Ageing Res Rev. 2024;94:102192. doi:10.1016/j.arr.2024.102192

15. Budd Haeberlein S, Aisen PS, Barkhof F, et al. Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease. J Prev Alzheimers Dis. 2022;9(2):197-210. doi:10.14283/jpad.2022.30

16. Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol. 2023;19(12):715-736. doi:10.1038/s41582-023-00883-2

17. Parrocha CMT, Nowick JS. Current Peptide Vaccine and Immunotherapy Approaches Against Alzheimer's Disease. Pept Sci (Hoboken). 2023;115(1):e24289. doi:10.1002/pep2.24289

18. Khan S, Barve KH, Kumar MS. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Curr Neuropharmacol. 2020;18(11):1106-1125. doi:10.2174/1570159X18666200528142429

19. Weninger S, Sperling B, Alexander R, et al. Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease. Alzheimers Dement (N Y). 2020;6(1):e12090. Published 2020 Oct 12. doi:10.1002/trc2.12090

20. Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches [published correction appears in Lancet Neurol. 2021 Feb;20(2):e2. doi: 10.1016/S1474-4422(21)00004-1.]. Lancet Neurol. 2021;20(1):68-80. doi:10.1016/S1474-4422(20)30412-9

21. Raikwar SP, Thangavel R, Dubova I, et al. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?. J Alzheimers Dis. 2018;65(2):321-344. doi:10.3233/JAD-180422

Quality in Sport

Downloads

  • PDF

Published

2025-05-12

How to Cite

1.
SKUBA, Adriana, ZAŁUSKA, Katarzyna, ŚWIDNIAK, Agnieszka, BISKUP, Marta, BARTOSZEK, Aleksandra, KOPEĆ, Karolina, MARUT, Agnieszka, MISIUK, Jagoda, ADAMIUK, Julia and NYKIEL, Sylwia. Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives. Quality in Sport. Online. 12 May 2025. Vol. 41, p. 58829. [Accessed 28 June 2025]. DOI 10.12775/QS.2025.41.58829.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 41 (2025)

Section

Medical Sciences

License

Copyright (c) 2025 Adriana Skuba, Katarzyna Załuska, Agnieszka Świdniak, Marta Biskup, Aleksandra Bartoszek, Karolina Kopeć, Agnieszka Marut, Jagoda Misiuk, Julia Adamiuk, Sylwia Nykiel

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 137
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

Alzheimer's disease, amyloid, tau, inflammation, dementia, acetylcho, acetylcholinesterase inhibitors, gene therapy
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop